mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.089 |
0.1 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.1 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
Imatinib |
FIMM |
pan-cancer |
AAC |
-0.27 |
0.1 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |